More importantly, PDIs overexpression in serous ovarian carcinoma correlates with patient survival, suggesting that PDI, PDIR, ERp57, ERp72 and AGR3 are potential prognostic markers for EOC. Here, AGR3 is linked to ovarian serous carcinoma.